Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:2760-2764

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tajima, M.
Right arrow Articles by Lorell, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tajima, M.
Right arrow Articles by Lorell, B. H.

(Circulation. 1998;98:2760-2764.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Atrial Natriuretic Peptide Has Different Effects on Contractility and Intracellular pH in Normal and Hypertrophied Myocytes From Pressure-Overloaded Hearts

Minori Tajima, MD, PhD; Jozef Bartunek, MD; Ellen O. Weinberg, PhD; Nobuhiko Ito, MD, PhD; Beverly H. Lorell, MD

From the Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory of Beth Israel Deaconess Medical Center and Department of Medicine (Cardiovascular Division, Beth Israel Deaconess Medical Center) and Harvard Medical School, Boston, Mass.

Correspondence to Beverly H. Lorell, MD, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215. E-mail blorell{at}bidmc.harvard.edu

Background—Atrial natriuretic peptide (ANP) depresses contractility in left ventricular myocytes. Its expression is upregulated in pressure-overloaded hypertrophied hearts; however, the effects of ANP on contractility in hypertrophied myocytes are not known. Our aims were (1) to examine the cellular mechanisms of this depression in contractility in normal myocytes and (2) to test the hypothesis that the effects of ANP on contractility differ in hypertrophied myocytes from rats with ascending aortic stenosis.

Methods and Results—We measured the myocyte shortening as an index of contractility, [Ca2+]i with fluo 3, and pHi with seminaphthorhodafluor-1 (SNARF-1). In normal control myocytes (n=26), ANP caused a concentration-dependent depression of contractility and reduction in pHi. In the presence of 10-6 mol/L ANP, fractional cell shortening was 78±5% of baseline (P<0.05) and pHi was reduced by 0.16±0.04 U from baseline (P<0.01) without changes in [Ca2+]i. The magnitude of the depression of contraction caused by ANP was similar to that caused by intracellular acidification induced by an NH4Cl pulse. The effects of ANP on contractility and pHi were prevented in the presence of 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), which inhibits the Na+/H+ exchanger. In hypertrophied myocytes (n=23), ANP did not depress either myocyte contractility or pHi at concentrations of either 10-8, 10-7, or 10-6 mol/L. ANP caused no change in pHi or the [Ca2+]i transient in hypertrophied myocytes. The cGMP level was increased and Na+/H+ exchanger mRNA levels were normal in left ventricles from aortic stenosis rats compared with controls.

Conclusions—ANP directly depresses contractility in normal myocytes via intracellular acidification, which decreases myofilament [Ca2+]i sensitivity. In contrast, ANP causes no effects on contractility and pHi in hypertrophied myocytes, suggesting a suppression in the coupling of the ANP-cGMP intracellular signaling pathway to the Na+/H+ exchanger.


Key Words: atrial natriuretic factor • hypertrophy • myocytes • contractility • calcium




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. William, E. J. Hamilton, A. Garcia, H. Bundgaard, K. K. M. Chia, G. A. Figtree, and H. H. Rasmussen
Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1067 - C1073.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kilic, A. Bubikat, B. Gassner, H. A. Baba, and M. Kuhn
Local Actions of Atrial Natriuretic Peptide Counteract Angiotensin II Stimulated Cardiac Remodeling
Endocrinology, September 1, 2007; 148(9): 4162 - 4169.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. E. Cingolani and I. L. Ennis
Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy
Circulation, March 6, 2007; 115(9): 1090 - 1100.
[Full Text] [PDF]


Home page
CirculationHome page
A. Kilic, A. Velic, L. J. De Windt, L. Fabritz, M. Voss, D. Mitko, M. Zwiener, H. A. Baba, M. van Eickels, E. Schlatter, et al.
Enhanced Activity of the Myocardial Na+/H+ Exchanger NHE-1 Contributes to Cardiac Remodeling in Atrial Natriuretic Peptide Receptor-Deficient Mice
Circulation, October 11, 2005; 112(15): 2307 - 2317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Su, Q. Zhang, J. Moalem, J. Tse, P. M. Scholz, and H. R. Weiss
Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1367 - H1373.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Sangawa, K. Nakanishi, K. Ishino, M. Inoue, M. Kawada, and S. Sano
Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart
Ann. Thorac. Surg., January 1, 2004; 77(1): 233 - 237.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ito, M. Nakayama, F. Hasan, X. Yan, M. D. Schneider, and B. H. Lorell
Contractile Reserve and Calcium Regulation Are Depressed in Myocytes From Chronically Unloaded Hearts
Circulation, March 4, 2003; 107(8): 1176 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P.R Kalra, S.D Anker, A.D Struthers, and A.J.S Coats
The role of C-type natriuretic peptide in cardiovascular medicine
Eur. Heart J., June 2, 2001; 22(12): 997 - 1007.
[PDF]


Home page
Circ. Res.Home page
K. Ito, X. Yan, M. Tajima, Z. Su, W. H. Barry, and B. H. Lorell
Contractile Reserve and Intracellular Calcium Regulation in Mouse Myocytes From Normal and Hypertrophied Failing Hearts
Circ. Res., September 29, 2000; 87(7): 588 - 595.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Yokoyama, S. Gunasegaram, S. E. Harding, and M. Avkiran
Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Bartunek, E. O. Weinberg, M. Tajima, S. Rohrbach, S. E. Katz, P. S. Douglas, and B. H. Lorell
Chronic NG-Nitro-L-Arginine Methyl Ester-Induced Hypertension : Novel Molecular Adaptation to Systolic Load in Absence of Hypertrophy
Circulation, February 1, 2000; 101(4): 423 - 429.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Inserte, D. Garcia-Dorado, L. Agullo, A. Paniagua, and J. Soler-Soler
Urodilatin limits acute reperfusion injury in the isolated rat heart
Cardiovasc Res, January 14, 2000; 45(2): 351 - 359.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Ohte, C.-P. Cheng, M. Suzuki, and W. C. Little
Effects of Atrial Natriuretic Peptide on Left Ventricular Performance in Conscious Dogs Before and After Pacing-Induced Heart Failure
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 589 - 595.
[Abstract] [Full Text]